Clinical Trials Directory

Trials / Completed

CompletedNCT04937335

Craniopharyngioma With Tumoral Hemorrhage

Clinical Features and Risk Factors of Craniopharyngioma With Tumoral Hemorrhage

Status
Completed
Phase
Study type
Observational
Enrollment
185 (actual)
Sponsor
Tongji Hospital · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Clinical data of 185 consecutive patients receiving resective operation with a pathological diagnosis of craniopharyngioma in our hospital between January 2013 and February 2021 were collected. Among these patients, 18 of them were recognized as craniopharyngioma with tumoral hemorrhage during the operation.

Detailed description

For each case, age, gender, smoking status, alcohol intake, past history, symptoms, blood pressure, blood cell count, blood biochemical tests, coagulation tests, hormone tests, radiological results, surgical treatment and the outcome at discharge were collected. The first test result after admission and before the operation was taken for the items of blood tests with multiple times in the analysis.

Conditions

Interventions

TypeNameDescription
OTHERintratumoral hemorrhagePatients who were recognized as craniopharyngioma pathologically with tumoral hemorrhage observed during the operation were enrolled in the hemorrhage group.

Timeline

Start date
2013-01-01
Primary completion
2021-02-01
Completion
2021-02-01
First posted
2021-06-24
Last updated
2021-06-24

Source: ClinicalTrials.gov record NCT04937335. Inclusion in this directory is not an endorsement.